A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 42,152 shares of ROIV stock, worth $528,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,152
Previous 61,792 31.78%
Holding current value
$528,164
Previous $653,000 25.57%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$10.17 - $12.5 $199,738 - $245,500
-19,640 Reduced 31.78%
42,152 $486,000
Q2 2024

Jul 26, 2024

BUY
$10.36 - $11.74 $60,067 - $68,068
5,798 Added 10.35%
61,792 $653,000
Q1 2024

Apr 24, 2024

BUY
$9.87 - $11.8 $552,660 - $660,729
55,994 New
55,994 $590,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.83B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.